This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Oct;60(4):751-2.

doi: 10.1016/j.eururo.2011.07.054. Epub 2011 Aug 5.

OnabotulinumtoxinA in refractory neurogenic detrusor overactivity

Prokar Dasgupta

PMID: 21840118
DOI: 10.1016/j.eururo.2011.07.054

Editorial

OnabotulinumtoxinA in refractory neurogenic detrusor overactivity

Prokar Dasgupta. Eur Urol. 2011 Oct.

. 2011 Oct;60(4):751-2.

doi: 10.1016/j.eururo.2011.07.054. Epub 2011 Aug 5.

Author

Prokar Dasgupta

PMID: 21840118
DOI: 10.1016/j.eururo.2011.07.054

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C. Cruz F, et al. Eur Urol. 2011 Oct;60(4):742-50. doi: 10.1016/j.eururo.2011.07.002. Epub 2011 Jul 13. Eur Urol. 2011. PMID: 21798658 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

G0600698/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information